A patient with rheumatoid arthritis presents with mild pleural effusion and elevated ESR and CRP levels despite adherence to medication. Which nursing intervention is most appropriate to address the patient's respiratory symptoms caused by the pleural effusion?

B) Assist with incentive spirometry exercises

A) Encourage increased oral fluid intake

B) Assist with incentive spirometry exercises

C) Educate on the use of a bronchodilator

A patient with rheumatoid arthritis and new onset pleural effusion is experiencing increased respiratory symptoms and worsening joint pain. Laboratory results show elevated ESR and CRP levels. Which nursing intervention is most appropriate to prioritize at this time?

C) Collaborate with the healthcare provider to adjust the patient's medication regimen

A) Administer supplemental oxygen to alleviate respiratory distress

B) Encourage increased physical activity to reduce joint stiffness

C) Collaborate with the healthcare provider to adjust the patient's medication regimen

D) Implement a low-sodium diet to manage fluid retention

A patient with rheumatoid arthritis who recently started biologic therapy presents with a persistent dry cough, shortness of breath, and a low-grade fever. Her oxygen saturation is 90% on room air, and a CT scan shows increased pleural effusion and interstitial lung disease. Which nursing intervention is the priority to address her current condition?

A) Administer supplemental oxygen to improve oxygen saturation levels.

B) Educate the patient on lifestyle modifications to manage rheumatoid arthritis.

C) Encourage increased fluid intake to help reduce fever.

D) Discuss alternative non-biologic treatment options with the healthcare provider.

A patient with rheumatoid arthritis has developed interstitial lung disease and pleural effusion after starting a biologic agent. The healthcare team has decided to reduce the biologic agent dosage and initiate corticosteroids and broad-spectrum antibiotics. Which nursing action is the highest priority in this situation?

B) Assessing the patient's respiratory status and oxygen saturation frequently.

A) Monitoring the patient's joint pain and swelling regularly.

B) Assessing the patient's respiratory status and oxygen saturation frequently.

C) Educating the patient about the potential side effects of corticosteroids.

D) Ensuring the patient adheres to the scheduled antibiotic regimen.

A patient with rheumatoid arthritis and interstitial lung disease has been admitted for monitoring and management after adjustments to her treatment plan. Despite improvements in her respiratory rate and oxygen saturation, her inflammatory markers remain elevated, and she reports intermittent chest discomfort and fatigue. What is the most appropriate nursing action to address the patient's current symptoms while collaborating with the healthcare team?

D) Facilitate a meeting between the patient and the pulmonologist to discuss potential changes in her medication regimen.

A) Increase the frequency of monitoring her vital signs and report significant changes to the healthcare provider.

B) Educate the patient about reducing physical activity to manage fatigue and prevent exacerbation of symptoms.

C) Suggest an increase in corticosteroid dosage to the healthcare team to further address inflammation.

D) Facilitate a meeting between the patient and the pulmonologist to discuss potential changes in her medication regimen.

A patient with rheumatoid arthritis and interstitial lung disease is being monitored after a reduction in biologic agent dosage and initiation of broad-spectrum antibiotics. Despite improvement in respiratory status, inflammatory markers remain elevated. What should the nurse prioritize in collaboration with the interdisciplinary team to optimize the patient's care?

B) Recommend a consultation with a pulmonologist to address pulmonary complications.

A) Suggest increasing the dosage of corticosteroids to further reduce inflammation.

B) Recommend a consultation with a pulmonologist to address pulmonary complications.

C) Propose discontinuing the biologic agent entirely to minimize immunosuppression.

D) Advise initiating a new biologic agent to more effectively manage rheumatoid arthritis.

A patient with rheumatoid arthritis and a recent respiratory infection is experiencing signs of acute kidney injury (AKI) due to medication effects. Which of the following nursing interventions is most appropriate to address the patient's current condition and prevent further renal damage?

A) Encourage increased oral fluid intake and monitor urine output closely.

B) Instruct the patient to continue all current medications without change.

C) Advise the patient to immediately discontinue all medications to prevent nephrotoxicity.

D) Suggest the patient increase physical activity to manage joint pain and swelling.

A patient with rheumatoid arthritis and recent respiratory infection is experiencing signs of acute kidney injury and exacerbation of joint symptoms. Which nursing intervention is the priority to help manage this patient's condition?

A) Monitor the patient's intake and output closely to assess renal function.

B) Administer corticosteroids as ordered to reduce joint inflammation.

C) Educate the patient about the importance of adhering to the DMARDs regimen.

D) Prepare the patient for dialysis to address the acute kidney injury.

A patient with rheumatoid arthritis and recent adjustments to her medication regimen presents with mild anemia. Which nursing intervention is most appropriate to address the potential causes of anemia in this patient?

C) Monitor for signs of gastrointestinal bleeding and advise on the use of stool softeners.

A) Increase dietary intake of iron-rich foods such as red meat and leafy greens.

B) Administer vitamin B12 injections to improve red blood cell production.

C) Monitor for signs of gastrointestinal bleeding and advise on the use of stool softeners.

D) Recommend discontinuation of methotrexate to prevent further anemia.

Given the patient's recent development of mild anemia, which nursing intervention is most appropriate to address this complication while considering the patient's existing conditions?

B) Monitor the patient for signs of gastrointestinal bleeding and report any findings to the healthcare provider.

A) Encourage a high-protein diet to support increased hemoglobin synthesis.

B) Monitor the patient for signs of gastrointestinal bleeding and report any findings to the healthcare provider.

C) Administer erythropoietin therapy as prescribed to stimulate red blood cell production.

D) Increase the dosage of methotrexate to better control rheumatoid arthritis symptoms, reducing the inflammatory cause of anemia.

rheumatoid arthritis - Nursing Case Study

Pathophysiology

• Primary mechanism: Rheumatoid arthritis (RA) is primarily driven by an autoimmune response where the immune system mistakenly targets synovial joints. This leads to chronic inflammation as immune cells infiltrate synovial tissue, causing synovitis and joint swelling.

• Secondary mechanism: The persistent inflammation stimulates the proliferation of synovial cells and the formation of pannus, a thickened layer of tissue. Pannus invades and destroys cartilage and bone, causing joint deformity and loss of function.

• Key complication: If untreated, this destructive process can lead to irreversible joint damage and disability, significantly impacting a patient's quality of life and necessitating comprehensive management strategies.

Patient Profile

Demographics:

45-year-old female, office worker

History:

• Key past medical history: Diagnosed with rheumatoid arthritis 5 years ago, hypertension

• Current medications: Methotrexate, Prednisone, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased joint pain and swelling

• Key symptoms: Morning stiffness lasting over an hour, fatigue, difficulty performing daily tasks, development of rheumatoid nodules

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 20 breaths per minute, temperature 99.1°F

Section 1

New Complications

Over the weeks following the initial presentation, the patient begins to experience increasing difficulty with breathing and persistent fatigue, prompting further evaluation. A chest X-ray reveals mild pleural effusion, a known extra-articular manifestation of rheumatoid arthritis. This complication arises when inflammation extends beyond the joints to involve the pleura, which can lead to the accumulation of fluid in the pleural space and subsequent respiratory symptoms. Additionally, the patient reports worsening morning stiffness and joint pain, despite adherence to her current medication regimen, suggesting inadequate control of her rheumatoid arthritis.

Laboratory tests are ordered to assess the activity of the disease. The patient's erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are significantly elevated, indicating heightened systemic inflammation. Further, a complete blood count reveals mild anemia of chronic disease, commonly observed in patients with active RA due to chronic inflammation interfering with erythropoiesis. These findings point to a need for reassessment of the current management plan, including potential adjustments to her immunosuppressive therapy to better control the disease activity and prevent further complications.

Clinicians must now consider escalating the patient's treatment approach, perhaps by introducing biologic agents or adjusting the dosage of her current medications to mitigate her symptoms and address the pleural effusion. The interdisciplinary team will also need to monitor her blood pressure closely, given the potential interactions of increased corticosteroid therapy with her hypertension. This case now calls for careful balancing of therapeutic interventions to manage her rheumatoid arthritis effectively while minimizing the risk of additional complications.

Section 2

Change in Patient Status

Following the introduction of a biologic agent to the patient's treatment regimen, there was initial optimism as the patient reported a slight improvement in joint pain and morning stiffness. However, within two weeks, the patient returned with concerning symptoms. She complained of a persistent dry cough, increased shortness of breath, and a low-grade fever. These new manifestations prompted a re-evaluation of her condition, as they raised suspicion for a possible infection, a known risk associated with immunosuppressive therapy. Upon examination, her vital signs showed a temperature of 100.4°F, respiratory rate of 24 breaths per minute, and an oxygen saturation level of 90% on room air, indicating respiratory compromise.

A repeat chest X-ray and high-resolution CT scan of the chest were ordered, revealing increased pleural effusion and the development of interstitial lung disease, another extra-articular complication of rheumatoid arthritis. These findings confirmed that the inflammation in her pleura had progressed, possibly exacerbated by the new biologic therapy. Given the patient's respiratory status and the potential for further deterioration, the healthcare team faced the challenge of managing the delicate balance between controlling her rheumatoid arthritis and minimizing the risk of infection and additional pulmonary complications.

In response, the team decided to temporarily reduce the biologic agent dosage and initiate a course of broad-spectrum antibiotics to address the suspected infection. Concurrently, they increased her corticosteroid therapy to manage the inflammation and pleural effusion. The patient's status required close monitoring, with frequent assessment of her respiratory function and inflammatory markers to guide further adjustments to her treatment plan. This case underscores the complexity of treating rheumatoid arthritis with systemic involvement and highlights the necessity for vigilant clinical reasoning to navigate the evolving challenges in her care.

Section 3

Response to Interventions

Following the adjustment in her treatment plan, the patient was admitted for closer monitoring and management. Over the next few days, the healthcare team observed her response to the interventions. The initial reduction in the biologic agent dosage, combined with the administration of broad-spectrum antibiotics, appeared to stabilize her condition. Her respiratory rate gradually decreased to 20 breaths per minute, and her oxygen saturation improved to 94% on room air. This suggested a positive response to the antibiotics, indicating that the suspected infection was being effectively managed.

However, her inflammatory markers, including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), remained elevated, signifying ongoing inflammation. The increased corticosteroid therapy helped alleviate some of the pleural effusion, but the patient continued to report intermittent chest discomfort and fatigue. This necessitated further evaluation of her treatment regimen to ensure a comprehensive approach to managing both her rheumatoid arthritis and pulmonary complications.

The care team decided to consult a pulmonologist to gain additional insights into managing her interstitial lung disease. This collaboration aimed to refine her treatment strategy, balancing the need for immunosuppression with the risk of exacerbating her lung condition. As the team worked to optimize her medication regimen, they remained vigilant for any signs of new complications or adverse effects. This phase of her care highlighted the importance of interdisciplinary collaboration and continuous reassessment to navigate the complexities of her evolving health status.

Section 4

New Complications

As the healthcare team continued to monitor the patient closely, new complications began to emerge, necessitating a reevaluation of her treatment plan. Despite initial improvements in her respiratory status, the patient started to exhibit signs of renal impairment. Laboratory results revealed a notable increase in serum creatinine levels to 2.1 mg/dL from a baseline of 0.9 mg/dL, alongside a decrease in glomerular filtration rate (GFR) to 45 mL/min/1.73 m². These changes indicated the onset of acute kidney injury, likely secondary to the increased use of corticosteroids and the potential nephrotoxic effects of the antibiotics administered.

The patient also began experiencing worsening joint pain and swelling, with the physical examination revealing significant synovitis in her wrists and knees. This exacerbation of her rheumatoid arthritis symptoms was corroborated by persistently high inflammatory markers, with CRP at 65 mg/L and ESR at 70 mm/hr. These findings suggested that while the infection was being managed, the inflammatory process associated with her rheumatoid arthritis was not adequately controlled, possibly due to the reduced dosage of the biologic agent.

Recognizing the need for a delicate balance in her treatment, the healthcare team, in consultation with a nephrologist, decided to adjust her medication regimen to mitigate renal stress while enhancing control of her arthritis symptoms. This included cautiously tapering the corticosteroids and considering alternative antibiotics with a safer renal profile. Additionally, the rheumatology team was consulted to explore potential adjustments in her disease-modifying antirheumatic drugs (DMARDs) to better address the inflammatory component without further compromising her renal function. This phase underscored the importance of comprehensive management and interdisciplinary collaboration in addressing the multifaceted challenges of her condition.

Section 5

As the healthcare team implemented the revised treatment plan, they closely monitored the patient's response to the interventions. Within a week, there were notable changes in her clinical status. The patient's renal function showed slight improvement, with serum creatinine levels decreasing to 1.8 mg/dL and GFR rising to 52 mL/min/1.73 m², indicating a positive response to the adjustment in her medication regimen. This improvement suggested that the tapering of corticosteroids and the switch to renal-friendly antibiotics were effective in reducing renal stress.

However, the patient's rheumatoid arthritis symptoms continued to pose significant challenges. The joint pain and swelling persisted, and while the inflammatory markers showed a marginal decrease, with CRP at 58 mg/L and ESR at 65 mm/hr, these levels remained elevated. During the physical examination, the patient reported increased stiffness in the morning, lasting over an hour, which was indicative of ongoing active inflammation. The rheumatology team decided to introduce a different DMARD, methotrexate, alongside her existing regimen, in hopes of achieving better control over the disease activity.

Despite these efforts, the patient began to experience new complications. She developed mild anemia, with her hemoglobin levels dropping to 10.5 g/dL from a previous 12.8 g/dL. This prompted further investigation to rule out potential causes such as gastrointestinal bleeding or bone marrow suppression, both of which could be related to her medication or underlying disease. The team emphasized the need for regular monitoring of her blood counts and discussed the potential need for iron supplementation or erythropoietin therapy, depending on the evolving clinical picture. This phase highlighted the complexity of managing coexisting conditions and the importance of ongoing assessment to guide therapeutic decisions.